This provider's $58.3M in total Medicare payments ranks in the 98th percentile of Clinical Laboratory providers nationally.
This provider's billing patterns fall within normal ranges for their specialty.
AI-generated analysis based on Medicare payment data.
Average per-service amounts submitted by the provider compared to what Medicare actually paid — the gap represents the markup.
| Year | Avg Submitted | Avg Paid | Markup Ratio | Gap per Service | Total Payments | Services | Beneficiaries |
|---|---|---|---|---|---|---|---|
| 2014 | $124.11 | $44.06 | 2.82x | $80.05 | $5.2M | 117.3K | 39 |
| 2015 | $122.62 | $43.40 | 2.83x | $79.22 | $4.9M | 112.1K | 43 |
| 2016 | $120.48 | $42.52 | 2.83x | $77.96 | $5.4M | 126.0K | 52 |
| 2017 | $118.99 | $41.98 | 2.83x | $77.01 | $5.7M | 136.9K | 52 |
| 2018 | $118.31 | $37.87 | 3.12x | $80.44 | $5.5M | 144.3K | 59 |
| 2019 | $118.25 | $34.45 | 3.43x | $83.80 | $4.9M | 142.9K | 55 |
| 2020 | $157.65 | $50.28 | 3.14x | $107.37 | $7.3M | 144.8K | 61 |
| 2021 | $133.46 | $38.49 | 3.47x | $94.97 | $8.3M | 214.6K | 64 |
| 2022 | $126.22 | $34.13 | 3.70x | $92.09 | $5.6M | 165.0K | 60 |
| 2023 | $123.32 | $32.38 | 3.81x | $90.94 | $5.6M | 172.7K | 61 |
| Code | Description | Services | Payments | Avg/Service | Markup |
|---|---|---|---|---|---|
| 87798 | Detection test by nucleic acid for organism, amplified probe technique | 412.1K | $16.3M | $39.50 | 3.28x |
| 87481 | Detection test for candida species (yeast), amplified probe technique | 258.2K | $10.4M | $40.10 | 3.24x |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 79.2K | $6.9M | $87.11 | 2.98x |
| 87511 | Detection test for gardnerella vaginalis (bacteria), amplified probe technique | 99.5K | $4.1M | $41.61 | 3.12x |
| 87661 | Detection test by nucleic acid for trichomonas vaginalis (genital parasite), amplified probe technique | 56.2K | $2.4M | $41.95 | 3.10x |
| 87653 | Detection test by nucleic acid for strep (streptococcus, group b), amplified probe technique | 53.0K | $2.2M | $41.18 | 3.15x |
| 88175 | Pap test, automated thin layer preparation; automated system and manual rescreening | 56.5K | $1.7M | $30.67 | 2.45x |
| 87529 | Detection test by nucleic acid for herpes simplex virus, amplified probe technique | 37.1K | $1.6M | $42.28 | 3.07x |
| 87640 | Detection test by nucleic acid for staphylococcus aureus (bacteria), amplified probe technique | 36.4K | $1.5M | $40.57 | 3.19x |
| 87491 | Detection test by nucleic acid for chlamydia trachomatis, amplified probe technique | 32.9K | $1.3M | $40.34 | 3.22x |
| 87591 | Detection test by nucleic acid for neisseria gonorrhoeae (gonorrhoeae bacteria), amplified probe technique | 32.1K | $1.3M | $40.36 | 3.22x |
| 87624 | Detection test by nucleic acid for human papillomavirus (hpv), high-risk types | 31.6K | $1.3M | $40.28 | 4.22x |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within | 34.7K | $867.6K | $24.98 | 1.80x |
| 86617 | Confirmation test for antibody to borrelia burgdorferi (lyme disease bacteria) | 26.4K | $465.4K | $17.65 | 4.53x |
| 87563 | Detection of mycoplasma genitalium by dna or rna probe | 11.5K | $398.7K | $34.62 | 3.74x |
| 86618 | Analysis for antibody borrelia burgdorferi (lyme disease bacteria) | 19.3K | $376.3K | $19.47 | 3.59x |
| 87641 | Detection test by nucleic acid for staphylococcus aureus, methicillin resistant (mrsa bacteria), amplified probe technique | 9.0K | $370.9K | $41.31 | 3.15x |
| 87651 | Detection test by nucleic acid for strep (streptococcus, group a), amplified probe technique | 7.2K | $293.9K | $40.92 | 3.18x |
| 86753 | Analysis for antibody to protozoa (parasite) | 18.6K | $264.6K | $14.19 | 4.93x |
| 87476 | Detection by nucleic acid for borrelia burgdorferi (bacteria), amplified probe technique | 6.3K | $256.0K | $40.71 | 3.19x |
This provider submits charges 3.21 times higher than what Medicare actually pays.
A markup ratio of 3.21x means for every $100 Medicare pays, this provider initially charges $321. This is higher than the national average.
Always verify provider credentials and location before scheduling appointments. This data reflects Medicare payments and may not include all practice locations.
Other Clinical Laboratory providers in NJ for peer comparison.
| Provider | Location | Total Payments | Status |
|---|---|---|---|
| Laboratory Corporation Of America Holdings | Raritan, NJ | $1.2B | ⚠️ Flagged |
| Quest Diagnostics Incorporated | Clifton, NJ | $927.2M | ⚠️ Flagged |
| Bioreference Health, Llc | Elmwood Park, NJ | $841.0M | ⚠️ Flagged |
| Accu Reference Medical Lab, Llc | Linden, NJ | $204.9M | ⚠️ Flagged |
| Aculabs Inc | East Brunswick, NJ | $91.5M | ✓ Clear |
Share this provider's Medicare payment information
Last Updated: February 2026 (data through 2023, the latest CMS release)
Note: All data is from publicly available Medicare records. OpenMedicare is an independent journalism project not affiliated with CMS.
Believe this data is inaccurate? Dispute this data